- US12285460utility2025Pharmaceutical Compositions0 cites
- US12263202utility2025Method of Treating Melanocortin-4 Receptor Pathway-associated Disorders0 cites
- US12077612utility2024Peptide Compositions0 cites
- US11702448utility2023Method of Treating Melanocortin-4 Receptor-associated Disorders in Heterozygous Carriers0 cites